Search
Search
Dr. Abraham Rudnick
- Schizophrenia
- Psychiatric rehabilitation
- Ethics and philosphy of medicine
- Recovery, arts/leisure and mental health
- Supported education
- Supported employment
Dr. Alexander J. Mao
- Clinical assessment of new devices in eye care
- Clinical outcome research in visual sciences
Dr. David Hill
D.Phil, FCAHS
Contact Information
Research published in 2016 has identified a population of progenitor cells within the pancreas of mice and human that can give rise to new insulin-producing cells in vitro. These were not predominantly located in situ within the mature islets of Langerhans, but in small clusters of endocrine cells throughout the pancreas. The total number of progenitor cells was high in early life but declined with age. This suggests that progenitor cells with the potential to become insulin-producing cells exist throughout life and may represent a source of β-cell plasticity to reverse diabetes. As a step towards mobilizing these cells we have examined the ability of grafted bone marrow-derived stem cells to reverse diabetes in mice. Marrow-derived cells migrated to the diabetic pancreas and specifically activated progenitor beta cell proliferation.
We completed in 2016 a Pan-European clinical trial for the prevention of gestational diabetes. We are now following up both women and their offspring from the previous study to determine the extent to which interventions in pregnancy alter the development of subsequent type 2 diabetes in the mothers, and the development of obesity and glucose intolerance in the offspring.
Dr. David Hill holds the Lawson Professorship in Diabetes Research and is a Professor in the Departments of Medicine, Physiology & Pharmacology and Paediatrics, at Western University. He is Scientific Director of Lawson Health Research Institute and the Integrated Vice President, Research for London Health Sciences Centre and St. Joseph’s Health Care London.
Educated at the University of Nottingham and at Worcester College, University of Oxford, he has published over 200 scientific papers and maintains an active program in diabetes research and stem cell biology. He is a recipient of the CDA’s Frederick G. Banting Award, as well as of the Medal of the Society for Endocrinology from the UK. Dr. Hill was inducted as a fellow of the Canadian Academy of Health Sciences (CAHS) in 2011.
Dr. Hill’s research centres on the generation of new insulin producing beta cells in the pancreas as a strategy for the reversal of diabetes
Dr. Ali Islam
- Image registration using cardiac CT and MRI
- Velocity mapping with cardiac MRI
- Radiology collaboration tools
- Integrating radiology
- Picture archival and communciations systems (PACS) with mobile devices
Dr. Alp Sener
- Establishing novel strategies of minimizing post-transplant graft rejection
- Promoting improved early and late renal allograft survival using both in vitro and in vivo models for donor tissue and cell modification
Dr. Anat Kornecki
- Breast imaging
Dr. Anurag Bhalla
BHSc (Honours), McMaster University
MD, Western University
FRCPC Internal Medicine and Respirology
MSc, Physiology and Phamacology, McMaster University
Contact Information
Asthma, sputum cell counts, eosinophils.
Anurag Bhalla is an Assisstant Professor of Medicine in Department of Medicine, Division of Respirology at Western University and Staff Respirologist at St. Joseph's Healthcare and London Health Sciences Centre.
He completed his medical school and internal medicine residency at Western University followed by respirology residency at McMaster University. Subsequently, he completed airway disease clinical fellowship and MSc in physiology and pharmacology with Dr. Parameswaran Nair at McMaster University.
His clinical interest includes complex airway diseases, including asthma, COPD and bronchiectasis. His research interest includes severe asthma, eosinophil biology, asthma biologics and airway inflammometery.
Dr. Arlene MacDougall appointed Director of Research and Innovation for St. Joseph’s Mental Health Care
Dr. Arlene MacDougall has been appointed as Director of Research and Innovation for mental health care at St. Joseph’s Health Care London and Lawson Health Research Institute.
She will oversee and facilitate all mental health care research at both Parkwood Institute and Southwest Centre for Forensic Mental Health Care, working to develop strong local and global partnerships, engage patients and their caregivers in research activities, and foster trans-disciplinary approaches to research.
Her goal is to build on existing research strengths in mood disorders, suicide and smart technology. She also will look to develop research links between Mental Health and Parkwood Institute’s other major research programs, Cognitive Vitality and Brain Health, and Mobility and Activity.
Dr. MacDougall joined Lawson and the Department of Psychiatry at the Schulich School of Medicine & Dentistry, Western University in 2013 working with the Prevention and Early Intervention Program for Psychoses at London Health Sciences Centre. Last year she was cross appointed to the Department of Epidemiology and Biostatistics at Schulich.
“I come to this new role with a great deal of optimism, energy and enthusiasm. Parkwood Institute Research has a number of established strengths in the mental health care field as well as potential for new streams of research and innovation,” says Dr. MacDougall. “I look forward to working with researchers, staff, and patients and their supporters, as well as academic and community partners, to make Parkwood Institute a leading centre in Canada for mental health research.”
Parkwood Institute Research is a Lawson program that represents inter-disciplinary clinical research and focuses on the advancement of innovations and discoveries that directly improve patient care.
Dr. MacDougall will continue her own program of research, which includes recovery-oriented interventions for people with serious mental illness locally and in Africa. She is leading local studies on the use of mindfulness meditation and participatory video interventions to promote recovery among youth with early psychosis. She is also leading a project based in Kenya using social businesses and a low cost psychosocial rehabilitation toolkit to create meaningful employment, promote social inclusion and support the overall functioning and recovery of people with serious mental illness in low income settings.
Most recently she has been involved in developing and leading initiatives that use social innovation approaches to tackle complex mental health system challenges both locally and globally.
At Western, she is the Director of Global MINDS (Mental Health Incubator for Disruptive Solutions) @ Western, an educational and research initiative that supports students, faculty and community stakeholders to create solutions that will reduce the global burden of mental disorders. Global MINDS is focused on innovating for low and middle income countries and for marginalized communities in Canada. Another initiative, MINDS of London-Middlesex, is working with multiple local stakeholders to collaboratively establish a social innovation lab and use collective impact approaches that will lead to solutions that address complex challenges in the local mental health system.
Dr. MacDougall began her new role on February 1, 2017 and joins Drs. Michael Borrie and Tim Doherty as Joint/Acting Beryl and Richard Ivey Research Chair in Aging, Mental Health, Rehabilitation and Recovery. She also joins Lawson’s Research Executive Committee as Assistant Director (interim) for Parkwood Institute Research, Mental Health.
Dr. Arun Prakash
- Psychopharmacology
- Forensic psychiatry
Dr. Brian J. Larocque
- Perioperative care
Dr. Brian Rotenberg
Contact Information
- Minimally invasive neurosurgery
- Sleep apnea surgery
- Sleep apnea public health
- Chronic diseases
- Neuroscience
Dr. Charlotte McDonald
- Type 2 diabetes
- Type 1 diabetes
Dr. Cheryl Forchuk recognized for health care innovation
Dr. Cheryl Forchuk is the recipient of the 2020 Innovation Award for her work to prevent discharges from hospital to homelessness. Throughout her career, Dr. Forchuk has been investigating potential best practice approaches to prevent homelessness in our community for a wide range of people, including those with severe mental illness, veterans, families, and youth.
Her recent project, ‘Preventing Hospital Discharge into Homelessness: No Fixed Address Version 2 (NFAv2)’ streamlines housing and income services by bringing them into the hospital, and integrating them into a coordinated system of care.
Research shows that when someone is housed, their use of medical and social services decreases. Safe and adequate housing is required for individuals to recover from illness.
Version one of this program was a great success, providing direct access to a housing advocate and Ontario Works from inpatient hospital psychiatric units in London. The No Fixed Address v2 program provides individual inpatients, at risk of becoming homeless, with housing and financial assistance while in hospital. A collaborative approach which includes the local Canadian Mental Health Association, the Salvation Army Rent Stability Bank, Ontario Works, and the City of London brings community supports to the hospital. This enables patients to recover from their illness and reduces the number who may return to the hospital. Dr. Forchuk’s use of in-depth, individual, quantitative interviews, and qualitative focus groups, allows stakeholders to voice their experiences with the program as well as capture traditional outcomes.
“This innovative program has been so successful in London’s hospitals that the City of London has integrated the NFAv2 service within its municipal housing support programs,” explains Dr. Arlene MacDougall, Lawson Scientist and Dr. Forchuk’s nominator. “It also has the potential to be integrated across the province as the best practice in reducing homelessness in communities. Her efforts have been recognized by multiple funding agencies, and it will soon be the model for the rest of the nation to follow. Dr. Forchuk’s commitment to improve the lives and of those in our community makes her truly deserving of this award.”
“The No Fixed Address research project is the first evaluation anywhere of a strategy that aims to reduce the number of hospital patients being discharged into homelessness,” says Dr. Forchuk. “I’m really proud of our collective efforts. We have been able to help a lot of people, and have also learned a lot throughout the course of this study.”
Dr. Clark Heard
Doctorate - Occupational Therapy - Temple University (Philadelphia, PA, USA)
Bachelor of Health Sciences - Occupational Therapy - McMaster University (Hamilton, ON, Canada)
- Focused on occupation, outcomes and the human experience of spirituality
Dr. Clark Heard is a staff occupational therapist at the Southwest Centre for Forensic Mental Health Care in St. Thomas, Ontario, Canada. Clark is also Adjunct Research Professor at the School of Occupational Therapy at Western University. A graduate of McMaster University (Hamilton, ON) and Temple University (Philadelphia, PA), Clark has a high volume of scholarly publication and has clinically precepted more than 125 occupational therapy students. A recipient of multiple teaching awards, Clark was nationally recognized by the Canadian Association of Occupational Therapists in 2015.Clark Has also been recognized with the Sister's of St. Joseph Award for Excellence in Care.
https://www.sjhc.london.on.ca/news-and-media/our-stories/unsung-heroes
Dr. Alexandre Legros
PhD
His background mainly relates to the effects of specific electromagnetic stimuli (from DBS to power-frequency magnetic fields) on human brain processing, motor control and cognitive functions. Dr Legros is managing an international industrial and scientific collaborations through industry-partnered academic support from the Canadian Institute of Health Research (CIHR).
He has expertise in acquisition and analysis of brain electric and metabolic signals (EEG, fMRI), subtle movement quantification and characterization (e.g. physiological tremor, standing balance), cognitive performances quantification, physiological monitoring (cardiovascular parameters).
Dr. Alexandre Legros is a full time scientist in the Imaging Program at Lawson, where he is the director of Human Threshold Research Group and Testing Facility. He is also an Associate Professor in the Departments of Medical Biophysics and Medical Imaging within the Schulich School of Medicine and Dentistry, and in the School of Kinesiology from within the Faculty of Health Sciences at Western University.
He received his PhD in Kinesiology in 2004 (University of Montpellier, France) and completed a first postdoctoral fellowship in neuroscience studying the impact of Deep Brain electric Stimulation (DBS) on patients implanted with electrodes suffering from dystonic syndromes (Neurosurgical Unit, University of Montpellier, France). He started a second postdoctoral fellowship in the BEMS group at Lawson in 2005 before being recruited as a young scientist in September 2007.
Dr. Legros has expertise in the fields of neuroscience, kinesiology, biophysics, and he his currently promoting the use of mathematical neuroscience to study the interaction between time-varying magnetic fields and neuronal assemblies/networks.
Dr. Cory Yamashita
- Mechanisms of Acute Lung Injury and Multiple Organ Failure
- The role of Serum Hypercholesterolemia in acute lung injury
- The role of MMP-3 in acute lung injury
- Ventilator Induced Lung Injury
- Host defense peptides
- Antibiotic resistance
Dr. Dalton L. Wolfe
- Spinal Cord and Acquired Brain Injury Rehabilitation
- Implementation Science
- Activity-based therapies to promote neurorecovery
Dr. Dalton Wolfe is a Scientist at Parkwood Institute (SJHC London) and the leader of the R2P (Research 2 Practice) team that integrates clinical and research efforts to improve care and clinical outcomes. His primary research interest is in the area of knowledge mobilization and best practice implementation with a focus on physical activity and activity-based therapies in spinal cord injury and brain injury rehabilitation. He co-leads the Ontario SCI Implementation, Evaluation and Quality Care Consortium which focuses on implementation of quality indicators towards the enhancement of care across the 5-academic health centres involved in SCI rehabilitation in the province of Ontario. As part of the Parkwood Rehabilitation Innovations in Mobility Enhancement (PRIME) initiative he is focused on enhancing clinical decision-making to improve locomotor and other movement-related outcomes with activity-based therapies such as robotic, manual and FES-assisted therapies. As with many of the R2P initiatives this involves implementation science and participatory research methods to put in place practice-based research infrastructure that enables iterative knowledge generation as well as implementation. Dr. Wolfe Is currently accepting students at the Masters, Doctoral, and post-doctoral levels.
Latest News: https://www.lawsonresearch.ca/lawsonlink/prime-team
Dr. Darren Drosdowech
- Shoulder - clinical outcomes
- Shoulder - biomechanics
- Elbow